Long-Term Safety and Efficacy of the Novel Β3 -Adrenoreceptor Agonist Vibegron in Japanese Patients With Overactive Bladder: A Phase III Prospective Study
International Journal of Urology - United Kingdom
doi 10.1111/iju.13596
Full Text
Open PDFAbstract
Available in full text
Categories
Date
May 11, 2018
Authors
Publisher
Wiley